Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States of America; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Biochim Biophys Acta Gene Regul Mech. 2021 Mar;1864(3):194691. doi: 10.1016/j.bbagrm.2021.194691. Epub 2021 Feb 6.
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with an estimated global prevalence of 1 in 4 individuals. Aberrant transcriptional control of gene expression is central to the pathophysiology of metabolic diseases. However, the molecular mechanisms leading to gene dysregulation are not well understood. Histone modifications play important roles in the control of transcription. Acetylation of histone 3 at lysine 9 (H3K9ac) is associated with transcriptional activity and is implicated in transcript elongation by controlling RNA polymerase II (RNAPII) pause-release. Hence, changes in this histone modification may shed information on novel pathways linking transcription control and metabolic dysfunction. Here, we carried out genome-wide analysis of H3K9ac in the liver of mice fed a control or a high-fat diet (an animal model of NAFLD), and asked whether this histone mark associates with changes in gene expression. We found that over 70% of RNAPII peaks in promoter-proximal regions overlapped with H3K9ac, consistent with a role of H3K9ac in the regulation of transcription. When comparing high-fat with control diet, approximately 17% of the differentially expressed genes were associated with changes in H3K9ac in their promoters, showing a strong correlation between changes in H3K9ac signal and gene expression. Overall, our data indicate that in response to a high-fat diet, dysregulated gene expression of a subset of genes may be attributable to changes in transcription elongation driven by H3K9ac. Our results point at an added mechanism of gene regulation that may be important in the development of metabolic diseases.
非酒精性脂肪性肝病 (NAFLD) 是最常见的慢性肝病,估计全球每四个人中就有一人患有这种病。基因表达的异常转录调控是代谢性疾病病理生理学的核心。然而,导致基因失调的分子机制尚不清楚。组蛋白修饰在转录控制中起着重要作用。组蛋白 3 赖氨酸 9 上的乙酰化 (H3K9ac) 与转录活性相关联,通过控制 RNA 聚合酶 II (RNAPII) 暂停释放,与转录延伸有关。因此,这种组蛋白修饰的变化可能提供有关连接转录控制和代谢功能障碍的新途径的信息。在这里,我们对喂食对照饮食或高脂肪饮食(NAFLD 的动物模型)的小鼠肝脏中的 H3K9ac 进行了全基因组分析,并询问这种组蛋白标记是否与基因表达的变化有关。我们发现,超过 70%的启动子近端区域的 RNAPII 峰与 H3K9ac 重叠,这表明 H3K9ac 在转录调控中起作用。当将高脂肪饮食与对照饮食进行比较时,大约 17%的差异表达基因与启动子中 H3K9ac 的变化有关,这表明 H3K9ac 信号和基因表达之间存在很强的相关性。总的来说,我们的数据表明,在高脂肪饮食的刺激下,一部分基因的表达失调可能归因于 H3K9ac 驱动的转录延伸的改变。我们的研究结果表明,在代谢性疾病的发展过程中,基因调控可能存在一种附加机制。